Channel
سلولهایبنیادیوسرطان
دکتر شریف مرادی استادیار پژوهشکده سلولهای بنیادی، پژوهشگاه رویان «این صفحه، شخصی است و ارتباط حقوقی با پژوهشگاه رویان ندارد». 🔺Email: [email protected] 🔺Instagram: https://www.instagram.com/pluricancer 🔺Eitaa: http://eitaa.com/pluricancer
Updated: 2026-10-19
Ad niches in this channel
Top advertisers in this channel
- 7@ecoshariff@ecoshariff
- 1@applymanspain@applymanspain
- 1@rostami_radpazehn@rostami_radpazehn
- 1@olkaplast1@olkaplast1
- 1@teravpnapp_bot@teravpnapp_bot
- 1@adsho@adsho
- 1@sharif_admin1@sharif_admin1
Activity
Research from the blog
- 2026-07-10
Ireland on Telegram Ads: The English-Language EU Bridge and Fintech-Hub Effect (2026)
How advertisers reach Irish audiences on Telegram — an English-speaking EU member inside the UK-Ireland creative pool, a fintech and tech-HQ hub, EU-regulated crypto and forex, and offshore gambling under a tightening licensing regime.
- 2026-07-10
United States on Telegram Ads: Offshore Betting, Licensed Crypto, and the Compliance Split (2026)
How brands advertise to US audiences on Telegram — the split between mainstream licensed operators and the offshore/crypto-native advertisers that dominate the channel, state-by-state betting law, SEC/CFTC constraints, and crypto-funded payment rails.
- 2026-05-07
Libertex Telegram Ads Profile: How Libertex Advertises in 2026
How Libertex runs sponsored Telegram campaigns in 2026 — creative formats, regional strategy, and what the tgadsspy archive reveals about this fintech brand.
- 2026-05-07
Revolut Telegram Ads Profile: How Revolut Advertises in 2026
How Revolut runs sponsored Telegram campaigns in 2026 — creative formats, regional strategy, and what the tgadsspy archive reveals about this fintech brand.
No ads indexed yet.
This channel was added to our crawler but no sponsored impressions have surfaced yet. Subscribe below — we will ping you on the first hit.
Tracked since 2026-04-24 · last ad check 2026-11-02 15:28 UTC